Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
J. appl. oral sci ; 25(5): 498-505, Sept.-Oct. 2017. tab, graf
Article Dans Anglais | LILACS, BBO | ID: biblio-893658

Résumé

Abstract Objective: This study aimed to evaluate the effects of continual intermittent administration of parathyroid hormone (PTH) on implant stability in the presence of osteoporosis, using rabbit models. Material and Methods: Fifteen female New Zealand white rabbits underwent ovariectomy and were administered glucocorticoids to induce osteoporosis, following which they were divided into three groups. The first group received intermittent subcutaneous PTH for 4 weeks until implant placement (PTH1), while the second and third groups received PTH (PTH2) and saline (control), respectively, for 4 weeks before and after implant placement. After intermittent administration of PTH or saline, titanium implants were inserted into the left femoral epiphyses of all animals, and the implant stability quotient (ISQ) was measured immediately after placement to assess the primary stability and at 2 and 4 weeks after implant placement to assess osseointegration. At 4 weeks after implant placement, histological and histomorphometric evaluations were conducted and the bone area around the implant socket was measured as a ratio of the total bone area to the total tissue area. Results: Regarding primary stability, the ISQ values for the PTH1 and PTH2 groups were significantly higher than those for the control group (p<0.05). Concerning osseointegration, the ISQ values at 2 and 4 weeks were significantly higher for the PTH2 group than for the PTH1 and control (p<0.05) groups. Histological assessments showed a thicker and more trabecular bone around the implant sockets in the PTH2 specimens than in the PTH1 and control specimens. The bone area around the implant socket was significantly greater in the PTH2 group than in the PTH1 and control groups (p<0.05). Conclusions: Our results suggest that continual intermittent PTH administration before and after dental implant placement is effective for the achievement of favorable stability and osseointegration in the presence of osteoporosis.


Sujets)
Animaux , Femelle , Lapins , Ostéoporose/physiopathologie , Hormone parathyroïdienne/administration et posologie , Implants dentaires , Ostéo-intégration/effets des médicaments et des substances chimiques , Agents de maintien de la densité osseuse/administration et posologie , Ostéoporose/anatomopathologie , Valeurs de référence , Facteurs temps , Ovariectomie , Reproductibilité des résultats , Ostéo-intégration/physiologie , Résultat thérapeutique , Remodelage osseux/effets des médicaments et des substances chimiques , Pose d'implant dentaire endo-osseux/méthodes , Modèles animaux de maladie humaine , Fémur/effets des médicaments et des substances chimiques , Fémur/anatomopathologie , Interface os-implant/physiopathologie , Analyse de fréquence de résonance , Glucocorticoïdes , Injections sous-cutanées
SÉLECTION CITATIONS
Détails de la recherche